Kronos Bio Inc
Change company Symbol lookup
Select an option...
KRON Kronos Bio Inc
NVSAW New Vista Acquisition Corp *W EXP 02/01/2026
$R25IGTRI Russell 2500 Growth TR Index
QQQ Invesco QQQ Trust
PRDO Perdoceo Education Corp
DITHF DS Smith PLC
BIOL BIOLASE Inc
GOEV Canoo Inc
CHE Chemed Corp
ASTA WorldFlix Inc
Go

Health Care : Biotechnology |
Company profile

Kronos Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of cancer therapeutics designed to target dysregulated transcription. Its product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks (TRNs) that drive their oncogenic activity. Its lead product candidate, entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase (SYK) inhibitor that is being developed for the treatment of acute myeloid leukemia (AML). Its second product candidate, KB-0742, is generated from its product engine’s small molecule microarray (SMM) platform. KB-0742 is designed to be an orally bioavailable inhibitor of CDK9 with a differentiated selectivity profile. Its KB-0742 is in advanced solid tumors with MYC genomic copy number gain (amplification).

Closing Price
$16.78
Day's Change
0.36 (2.19%)
Bid
--
Ask
--
B/A Size
--
Day's High
17.04
Day's Low
16.10
Volume
(Average)
Volume:
215,180

10-day average volume:
235,559
215,180

Thinking about trading options or stock in Apple, Nio, Plug Power, Affirm Holdings, or Quantumscape?

10:45 am ET October 8, 2021 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for AAPL, NIO, PLUG, AFRM, and QS.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- AAPL: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AAPL&prnumber=100820217

-- NIO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NIO&prnumber=100820217

-- PLUG: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PLUG&prnumber=100820217

-- AFRM: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AFRM&prnumber=100820217

-- QS: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=QS&prnumber=100820217

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

https://c212.net/c/img/favicon.png?sn=CG34055&sd=2021-10-08

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-apple-nio-plug-power-affirm-holdings-or-quantumscape-301396223.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG34055&Transmission_Id=202110081045PR_NEWS_USPR_____CG34055&DateId=20211008

comtex tracking

COMTEX_394791750/1005/2021-10-08T10:45:07

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.